Total dyspnoea

Current Opinion in Supportive and Palliative Care

Volumn 2, Issue 2, 2008, Pages 110-113

  Abernethy, Amy P ^a,b   Wheeler, Jane L ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b FLINDERS UNIVERSITY   (Australia)

Author keywords

Dyspnoea; Palliative care; Terminal care

Indexed keywords

AGED; CASE REPORT; DYSPNEA; HUMAN; MALE; NEOPLASM; PALLIATIVE THERAPY; PATHOPHYSIOLOGY; PSYCHOLOGICAL ASPECT; REVIEW; TERMINAL CARE;

AGED; DYSPNEA; HUMANS; MALE; NEOPLASMS; PALLIATIVE CARE; TERMINAL CARE;

EID: 55949121672     PISSN: 17514258     EISSN: 17514266     Source Type: Journal    
DOI: 10.1097/SPC.0b013e328300cad0     Document Type: Article

References (21)

1. Reuben DB, Mor V, Reuben DB, Mor V. Dyspnea in terminally ill cancer patients. Chest 1986; 89:234-236.
2. Del Fabbro E, Dalal S, Bruera E. Symptom control in palliative care. Part III: Dyspnea and delirium. J Palliat Med 2006; 9:422-436.
3. Saunders DC. Care of patients suffering from terminal illness at St. Joseph's Hospice, Hackney, London. Nurs Mirror 1964; a:vii-x.
4. Luce JM, Luce JA. Perspectives on care at the close of life. Management of dyspnea in patients with far-advanced lung disease: 'once I lose it, it's kind of hard to catch it.'. JAMA 2001; 285:1331 -1337.
5. Dyspnea. Mechanisms, assessment, and management: a consensus state- ment.AmericanThoracicSociety.AmJRespCritCareMed1999;159:321-340.
6. Cristiano LM, Schwartzstein RM. Effect of chest wall vibration on dyspnea during hypercapnia and exercise in chronic obstructive pulmonary disease.Am J Resp Crit Care Med 1997; 155:1552-1559.
7. O'Donnell DE, Webb KA. Exertional breathlessness in patients with chronic airflow limitation. The role of lung hyperinflation. Am Rev Resp Dis 1993;148:1351-1357.
8. Nishino T, Ide T, Sudo T, et al. Inhaled furosemide greatly alleviates the sensation of experimentally induced dyspnea. Am J Resp Crit Care Med 2000; 161:1963-1967.
9. Dudgeon DJ, Lertzman M. Dyspnea in the advanced cancer patient [see comment]. J Pain Symptom Manage 1998; 16:212-219.
10. Smith EL, Hann DM, Ahles TA, et al. Dyspnea, anxiety, body consciousness, and quality of life in patients with lung cancer. J Pain Symptom Manage 2001;21:323-329.
11. Booth S, Silvester S, Todd C, et al. Breathlessness in cancer and chronic obstructive pulmonary disease: using a qualitative approach to describe the experience of patients and carers. Palliat Support Care 2003; 1:337-344.
12. Seamark DA, Blake SD, Seamark CJ, et al. Living with severe chronic obstructive pulmonary disease (COPD): perceptions of patients and their carers. An interpretative phenomenological analysis. Palliat Med 2004;18:619-625.
13. Jennings AL, Davies AN, Higgins JP, et al. A systematic review of the use of opioids in the management of dyspnoea. Thorax 2002; 57:939-944.
14. Abernethy AP, Currow DC, Frith P, etal. Randomised, double blind, placebo controlled crossover trial of sustained release morphine for the management of refractory dyspnoea. BMJ 2003; 327:523-528.
15. Abernethy AP, Currow DC, Frith P, et al. Prescribing palliative oxygen: a clinician survey of expected benefit and patterns of use. Palliat Med 2005;19:168-170.
16. Stringer E, McParland C, Hernandez P, et al. Physician practices for prescribing supplemental oxygen in the palliative care setting. J Palliat Care 2004; 20:303-307.
17. Argyropoulou P, Patakas D, Koukou A, et al. Buspirone effect on breath- lessness and exercise performance in patients with chronic obstructive pulmonary disease. Respiration 1993; 60:216-220.
18. Singh NP, Despars JA, Stansbury DW, et al. Effects of buspirone on anxiety levels and exercise tolerance in patients with chronic airflow obstruction and mild anxiety. Chest 1993; 103:800-804.
19. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983; 67:361-370.
20. National Comprehensive Cancer Network. NCCN Clinical Practice Guide- lines in Oncology - Distress Management. Fort Washington, PA: National Comprehensive Cancer Network; 2007.
21. Peterman AH, Fitchett G, Brady MJ, et al. Measuring spiritual well being in people with cancer: the functional assessment of chronic illness therapy-spiritual well being Scale (FACIT-Sp). Ann Behav Med 2002; 24:49-58.